All Updates

All Updates

icon
Filter
Funding
Reprise raises USD 62 million in Series B funding
No-code Software
Nov 9, 2021
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Partnerships
Funding
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
No-code Software

No-code Software

Nov 9, 2021

Reprise raises USD 62 million in Series B funding

Funding

<ul><li>Reprise, a no-code platform for sales and marketing teams to build product demos, raised USD 62 million in Series B funding led by ICONIQ Growth with participation from Bain Capital Ventures, Accomplice VC, and Glasswing Ventures. This round comes just nine months after the company’s previous Series A funding round of USD 17 million and raises its total funding to USD 82 million.</ul> 

  • The funds will be used to expand the company’s customer base through sales and marketing efforts and to develop its enterprise platform. 

<ul><li> Analyst QuickTake : Reprise offers a similar product to both Demostack and Walnut , both of which raised funding earlier this year ( Demostack raised USD 13.3 million in March and Walnut raised USD 15 million at the end of August ). With this new funding round, Reprise becomes the highest funded no-code demo building platform in our coverage, ahead of Walnut’s USD 21 million. Reprise aims to differentiate itself from its competitors by focusing primarily on sales and marketing teams and enabling them to build external product demos.</ul> 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.